-
The FDA has approved the first fixed-dose combination product for the treatment of type 2 diabetes and hypercholesterolemia. This tablet combines a dipeptidyl peptidase-4 inhibitor (sitagliptin) and a HMG-CoA reductase inhibitor (simvastatin).
-
-
The objective of this study was to estimate the use of vte prophylaxis in women undergoing major gynecologic surgery and to estimate the patient, physician, and hospital characteristics associated with their use.
-
In this issue: New recommendations for HPV vaccine; guidelines for treatment of essential tremor; updates on smoking cessation drugs; and FDA actions.
-
As U.S. waistlines continue to grow, so does the concern regarding obesity's effects on health and health care.
-
-
-
In an otherwise normal preterm pregnancy, is oligohydramnios a reason to deliver? This question has popped up repeatedly, and an article in the September issue of the American Journal of Obstetrics and Gynecology addressed this conundrum.
-
The author informs us that the winner of the 2010 Tour de France was Alberto Contador, riding a Specialized SL3 racing bike. The U.S. rider Chris Horner finished 12 minutes behind riding a Trek, Madone. The best rookie finisher, Daniel Loyd, rode a Cervelo S3, and finished more than 4 hours behind the leaders.
-
To perform the study, researchers designed a pooled analysis of individual data from two large studies by the International Agency for Research on Cancer, an international collaboration on cancer research, and the Institut Català d'Oncologia, a Spanish-based oncology research program.
